Questo sito o gli strumenti terzi da questo utilizzati si avvalgono di cookie. Continuando a navigare nel sito si accetta l'utilizzo dei cookies. Per maggiori informazioni clicca su Privacy & Cookies Policy nel menu che trovi in fondo alla pagina a destra. (Cookie e Privacy Policy)


Nice, France 11-13 April 2019

Course description

Mitochondrial diseases are an important group of inherited metabolic disorders affecting children and adults, with an extremely wide range of clinical symptoms and an ever increasing number of genetic causes.

Since the identification of the first molecular anomalies 30 years ago, the clinical features and molecular basis of the main mitochondrial disorders have been deciphered. Major advances have been achieved in the diagnosis of these disorders in recent years, with the advent of improved molecular techniques.

Despite the lack of curative treatment for most mitochondrial disorders, multidisciplinary care may improve survival and quality of life of patients, and several organ dysfunctions may be treated with specific approaches. In addition, innovative therapies are now available for a few primary mitochondrial diseases, and clinical trials will probably increase in the near future.

An increased awareness of these disorders is therefore needed in order to facilitate earlier diagnosis and genetic counselling for affected families, to improve the multidisciplinary care of patients, and for clinical trial readiness.

Scarica il programma:

Nome file
Download this file (Mitochondrial medicine 30 years on state of the art, April 2019.pdf)Mitochondrial medicine 30 years on state of the art, April 2019.pdf[ ][ ][ ]355 kB2018-12-17 08:03